Animal Drugs-Europe Market Status and Trend Report 2013-2023
Report Summary
Animal Drugs-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Animal Drugs 2013-2017, and development forecast 2018-2023
Main market players of Animal Drugs in Europe, with company and product introduction, position in the Animal Drugs market
Market status and development trend of Animal Drugs by types and applications
Cost and profit status of Animal Drugs, and marketing status
Market growth drivers and challenges
The report segments the Europe Animal Drugs market as:
Europe Animal Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Animal Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anti-infective
Anti-inflammatory
Parasiticides
Europe Animal Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Livestock
Companion
Europe Animal Drugs Market: Players Segment Analysis (Company and Product introduction, Animal Drugs Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Bayer
Elanco Animal Health
Ceva
Dechra
Merck
Virbac
Vetoquinol
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Animal Drugs-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Animal Drugs industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Animal Drugs 2013-2017, and development forecast 2018-2023
Main market players of Animal Drugs in Europe, with company and product introduction, position in the Animal Drugs market
Market status and development trend of Animal Drugs by types and applications
Cost and profit status of Animal Drugs, and marketing status
Market growth drivers and challenges
The report segments the Europe Animal Drugs market as:
Europe Animal Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Animal Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anti-infective
Anti-inflammatory
Parasiticides
Europe Animal Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Livestock
Companion
Europe Animal Drugs Market: Players Segment Analysis (Company and Product introduction, Animal Drugs Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Bayer
Elanco Animal Health
Ceva
Dechra
Merck
Virbac
Vetoquinol
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ANIMAL DRUGS
1.1 Definition of Animal Drugs in This Report
1.2 Commercial Types of Animal Drugs
1.2.1 Anti-infective
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.3 Downstream Application of Animal Drugs
1.3.1 Livestock
1.3.2 Companion
1.4 Development History of Animal Drugs
1.5 Market Status and Trend of Animal Drugs 2013-2023
1.5.1 EMEA Animal Drugs Market Status and Trend 2013-2023
1.5.2 Regional Animal Drugs Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Drugs in EMEA 2013-2017
2.2 Consumption Market of Animal Drugs in EMEA by Regions
2.2.1 Consumption Volume of Animal Drugs in EMEA by Regions
2.2.2 Revenue of Animal Drugs in EMEA by Regions
2.3 Market Analysis of Animal Drugs in EMEA by Regions
2.3.1 Market Analysis of Animal Drugs in Europe 2013-2017
2.3.2 Market Analysis of Animal Drugs in Middle East 2013-2017
2.3.3 Market Analysis of Animal Drugs in Africa 2013-2017
2.4 Market Development Forecast of Animal Drugs in EMEA 2018-2023
2.4.1 Market Development Forecast of Animal Drugs in EMEA 2018-2023
2.4.2 Market Development Forecast of Animal Drugs by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Animal Drugs in EMEA by Types
3.1.2 Revenue of Animal Drugs in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Animal Drugs in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Drugs in EMEA by Downstream Industry
4.2 Demand Volume of Animal Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Drugs by Downstream Industry in Europe
4.2.2 Demand Volume of Animal Drugs by Downstream Industry in Middle East
4.2.3 Demand Volume of Animal Drugs by Downstream Industry in Africa
4.3 Market Forecast of Animal Drugs in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL DRUGS
5.1 EMEA Economy Situation and Trend Overview
5.2 Animal Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Animal Drugs in EMEA by Major Players
6.2 Revenue of Animal Drugs in EMEA by Major Players
6.3 Basic Information of Animal Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Animal Drugs Major Players
6.3.2 Employees and Revenue Level of Animal Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Animal Drugs Product
7.1.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Boehringer Ingelheim
7.2.1 Company profile
7.2.2 Representative Animal Drugs Product
7.2.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.3 Bayer
7.3.1 Company profile
7.3.2 Representative Animal Drugs Product
7.3.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Bayer
7.4 Elanco Animal Health
7.4.1 Company profile
7.4.2 Representative Animal Drugs Product
7.4.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Elanco Animal Health
7.5 Ceva
7.5.1 Company profile
7.5.2 Representative Animal Drugs Product
7.5.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Ceva
7.6 Dechra
7.6.1 Company profile
7.6.2 Representative Animal Drugs Product
7.6.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Dechra
7.7 Merck
7.7.1 Company profile
7.7.2 Representative Animal Drugs Product
7.7.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Merck
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Drugs Product
7.8.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol
7.9.1 Company profile
7.9.2 Representative Animal Drugs Product
7.9.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Vetoquinol
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL DRUGS
8.1 Industry Chain of Animal Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL DRUGS
9.1 Cost Structure Analysis of Animal Drugs
9.2 Raw Materials Cost Analysis of Animal Drugs
9.3 Labor Cost Analysis of Animal Drugs
9.4 Manufacturing Expenses Analysis of Animal Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Animal Drugs in This Report
1.2 Commercial Types of Animal Drugs
1.2.1 Anti-infective
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.3 Downstream Application of Animal Drugs
1.3.1 Livestock
1.3.2 Companion
1.4 Development History of Animal Drugs
1.5 Market Status and Trend of Animal Drugs 2013-2023
1.5.1 EMEA Animal Drugs Market Status and Trend 2013-2023
1.5.2 Regional Animal Drugs Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Animal Drugs in EMEA 2013-2017
2.2 Consumption Market of Animal Drugs in EMEA by Regions
2.2.1 Consumption Volume of Animal Drugs in EMEA by Regions
2.2.2 Revenue of Animal Drugs in EMEA by Regions
2.3 Market Analysis of Animal Drugs in EMEA by Regions
2.3.1 Market Analysis of Animal Drugs in Europe 2013-2017
2.3.2 Market Analysis of Animal Drugs in Middle East 2013-2017
2.3.3 Market Analysis of Animal Drugs in Africa 2013-2017
2.4 Market Development Forecast of Animal Drugs in EMEA 2018-2023
2.4.1 Market Development Forecast of Animal Drugs in EMEA 2018-2023
2.4.2 Market Development Forecast of Animal Drugs by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Animal Drugs in EMEA by Types
3.1.2 Revenue of Animal Drugs in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Animal Drugs in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Animal Drugs in EMEA by Downstream Industry
4.2 Demand Volume of Animal Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Animal Drugs by Downstream Industry in Europe
4.2.2 Demand Volume of Animal Drugs by Downstream Industry in Middle East
4.2.3 Demand Volume of Animal Drugs by Downstream Industry in Africa
4.3 Market Forecast of Animal Drugs in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ANIMAL DRUGS
5.1 EMEA Economy Situation and Trend Overview
5.2 Animal Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 ANIMAL DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Animal Drugs in EMEA by Major Players
6.2 Revenue of Animal Drugs in EMEA by Major Players
6.3 Basic Information of Animal Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Animal Drugs Major Players
6.3.2 Employees and Revenue Level of Animal Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ANIMAL DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Animal Drugs Product
7.1.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Boehringer Ingelheim
7.2.1 Company profile
7.2.2 Representative Animal Drugs Product
7.2.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.3 Bayer
7.3.1 Company profile
7.3.2 Representative Animal Drugs Product
7.3.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Bayer
7.4 Elanco Animal Health
7.4.1 Company profile
7.4.2 Representative Animal Drugs Product
7.4.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Elanco Animal Health
7.5 Ceva
7.5.1 Company profile
7.5.2 Representative Animal Drugs Product
7.5.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Ceva
7.6 Dechra
7.6.1 Company profile
7.6.2 Representative Animal Drugs Product
7.6.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Dechra
7.7 Merck
7.7.1 Company profile
7.7.2 Representative Animal Drugs Product
7.7.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Merck
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Animal Drugs Product
7.8.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol
7.9.1 Company profile
7.9.2 Representative Animal Drugs Product
7.9.3 Animal Drugs Sales, Revenue, Price and Gross Margin of Vetoquinol
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ANIMAL DRUGS
8.1 Industry Chain of Animal Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ANIMAL DRUGS
9.1 Cost Structure Analysis of Animal Drugs
9.2 Raw Materials Cost Analysis of Animal Drugs
9.3 Labor Cost Analysis of Animal Drugs
9.4 Manufacturing Expenses Analysis of Animal Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF ANIMAL DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
